ivermectin oral / Generic mfg. 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 


«12...8990919293949596979899...129130»
  • ||||||||||  ivermectin oral / Generic mfg.
    Enrollment change, Trial completion date, Trial initiation date, Trial primary completion date, Combination therapy:  SINZ-COVID-PK: Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients (clinicaltrials.gov) -  Jan 22, 2021   
    P1/2,  N=60, Recruiting, 
    N=40 --> 60 | Trial completion date: Sep 2020 --> Oct 2021 | Initiation date: Jul 2020 --> Nov 2020 | Trial primary completion date: Sep 2020 --> Aug 2021
  • ||||||||||  Actemra IV (tocilizumab) / Roche, JW Pharma, Soliris (eculizumab) / Alexion Pharma
    Clinical, Journal:  Evaluation of the initial response in clinical trial efforts for COVID-19 in Brazil. (Pubmed Central) -  Jan 21, 2021   
    The interventions evaluated during the Brazilian research response reflect those of international initiatives, but with a different distribution and a large number of studies assessing hydroxychloroquine/chloroquine. Limitations in methodological design and sample planning represent challenges that could affect the research outreach.